Nephrology

Patients without hepatitis C virus (HCV) infection who received pre-operative glecaprevir-pibrentasvir (Mavyret) prophylaxis were able to safely receive a kidney transplant from HCV-positive donors, according to a study published in Annals of Internal Medicine.

In this small single-center study, 10 HCV-negative patients who received kidney transplants from HCV-positive donors had no detectable viral RNA 7 days post-transplants. Viral RNA was undetectable for the 12-week follow-up period.

Read the full…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Mar 19, 2020

X-linked Hypophosphatemia Impacts Physical, Psychological Aspects of Quality of Life

A study published in the Kidney Week 2019 Supplement looked at the impact X-linked hypophosphatemia (XLH) had on quality of life.

XLH is characterized by low levels of phosphate in the blood. Patients often experience reduced mobility and…

Journal Scan

  1. Sep 08, 2020

HCV-infected kidney transplants possible after pre-operative DAAs

Patients without hepatitis C virus (HCV) infection who received pre-operative glecaprevir-pibrentasvir (Mavyret) prophylaxis were able to safely receive a kidney transplant from HCV-positive donors, according to a study published in Annals of Internal Medicine.